Research output per year
Research output per year
Personal profile
Research interests
Ovarian cancer, gynecologic cancer, chemotherapy resistance, DNA repair, epigenetic targets, tumor microenvironment, cancer health disparities
Clinical interests
Gynecologic oncology, ovarian cancer, endometrial cancer, cervical cancer, vulva cancer, adnexal masses, tumors, hysterectomy, lymphadenectomy, endometrial adenocarcinomas, cervical intraepithelial neoplasia, gynecologic malignancies, ob/gyn, women's health
Available to Mentor:
- PhD Students
Fingerprint
Dive into the research topics where Dineo Khabele is active. These topic labels come from the works of this person and are generated automatically. Together they form a unique fingerprint. Contact the Profiles team with questions.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Association of Tumor-Infiltrating Lymphocytes and Inflammation Status with Survival Outcome in Patients with High-Grade Serous Ovarian Carcinoma
Miceska, S., Grašič Kuhar, C., Frković Grazio, S., Škof, E., Krishnamoorthy, P., Khabele, D. & Kloboves Prevodnik, V., Jul 2025, In: Cancers. 17, 14, 2269.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Does interdisciplinary group care for the treatment of endometriosis improve pain interference: Protocol for a pilot randomised controlled trial at an urban academic medical centre
Ross, W. T., Buday, S., Yakel, E., Khabele, D., Balls-Berry, J., As-Sanie, S., Colditz, G. & Baumann, A. A., Mar 5 2025, In: BMJ Open. 15, 3, e097372.Research output: Contribution to journal › Article › peer-review
Open Access -
MECOM amplified endometrial cancer, a novel subset of copy number high tumors associated with poor prognosis
Harrington, S. P., Romani, J., Jatoi, A., Weroha, S. J., Mariani, A., Cliby, W. A., Bakkum-Gamez, J. N., Khabele, D. & Gaspar-Maia, A., Dec 2025, In: Gynecologic Oncology Reports. 62, 101993.Research output: Contribution to journal › Article › peer-review
Open Access -
Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination–proficient ovarian cancer
Schab, A., Compadre, A., Drexler, R., Loeb, M., Rodriguez, K., Brill, J., Harrington, S., Sandoval, C., Sanders, B., Kuroki, L., McCourt, C., Hagemann, A. R., Thaker, P., Mutch, D., Powell, M., Serra, V., Hagemann, I. S., Walts, A. E., Karlan, B. Y. & Orsulic, S. & 7 others, , Jul 1 2025, In: Journal of Clinical Investigation. 135, 13, e189511.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model
Gupta, V. G., Roby, K. F., Pathak, H. B., Godwin, A. K., Gunewardena, S. & Khabele, D., 2025, In: BMC Cancer. 25, 1, 233.Research output: Contribution to journal › Article › peer-review
Open Access